Mondelez (MDLZ) Appoints Brian McNamara to its Board
Get Alerts MDLZ Hot Sheet
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.5%
Revenue Growth %: +0.5%
Join SI Premium – FREE
Mondelēz International, Inc. (Nasdaq: MDLZ) today announced the appointment of Brian McNamara to the Company’s Board of Directors, effective Feb. 1. McNamara has served as Chief Executive Officer of Haleon plc, formerly GSK Consumer Healthcare, since May 2022. Previously, he led GSK’s Consumer Healthcare business.
“We are pleased to welcome Brian to our Board. His breadth and depth of expertise in all aspects of consumer products leadership – including supply chain, brand marketing, customer engagement and more – will provide valuable insight and strategic input to our team,” said Dirk Van de Put, Chairman & CEO of Mondelēz International.
Before joining GSK in 2015, McNamara held a variety of senior leadership positions for several global consumer products companies, including Novartis AG and The Procter & Gamble Company. He currently sits on Haleon’s Board of Directors, as well as the Board of Directors of the Consumer Goods Forum.
McNamara’s appointment expands the size of the Company’s Board to 11 members, 10 of whom are deemed independent, including McNamara.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PodcastOne (PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
- Moderna (MRNA) Receives U.S. FDA Approval for RSV Vaccine mRESVIA
- IFF (IFF) Appoints Margarita Palau-Hernandez to its Board
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!